Cargando…

EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells

OBJECTIVES: To investigate the role of EphA2 in malignant cellular behavior in renal cell carcinoma (RCC) cells and whether FAK/RhoA signaling can act as downstream effectors of EphA2 on RCC cells. METHODS: Expression of EphA2 protein in non-metastatic RCC (Caki-2 and A498), metastatic RCC cells (Ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Min Chul, Cho, Sung Yong, Yoon, Cheol Yong, Lee, Seung Bae, Kwak, Cheol, Kim, Hyeon Hoe, Jeong, Hyeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503437/ https://www.ncbi.nlm.nih.gov/pubmed/26177500 http://dx.doi.org/10.1371/journal.pone.0130975

Ejemplares similares

Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
por: Ruan, Hailong, et al.
Publicado: (2020)

Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
por: Ruan, Hailong, et al.
Publicado: (2022)

Predicting Factors for Death from Other Causes in Patients with Localized Renal Cell Carcinoma
por: Chang, Jin Suk, et al.
Publicado: (2012)

Association between decreased ipsilateral renal function and aggressive behavior in renal cell carcinoma
por: Han, Jang Hee, et al.
Publicado: (2022)

Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
por: Lee, Cheol, et al.
Publicado: (2013)

Novel immunotherapy in metastatic renal cell carcinoma
por: Cho, Yang Hyun, et al.
Publicado: (2017)

High EphA2 protein expression in renal cell carcinoma is associated with a poor disease outcome
por: XU, JINSHENG, et al.
Publicado: (2014)

A Comprehensive Prognostic Stratification for Patients with Metastatic Renal Clear Cell Carcinoma
por: Cho, Kang Su, et al.
Publicado: (2008)

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
por: Lee, Hakmin, et al.
Publicado: (2017)

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Influence of Tumor Thrombus on Occurrence of Distant Venous Thromboembolism and Survival in Patients With Renal Cell Carcinoma After Surgery
por: Park, Hyunkyung, et al.
Publicado: (2019)

Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population
por: Suh, Jungyo, et al.
Publicado: (2020)

Biology of Metastatic Renal Cell Carcinoma
por: Milella, Michele, et al.
Publicado: (2011)

Axitinib in Metastatic Renal Cell Carcinoma
por: Mittal, Kriti, et al.
Publicado: (2012)

Renal Cell Carcinoma Metastatic to the Scalp
por: Errami, Mounir, et al.
Publicado: (2016)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy
por: Lee, Hakmin, et al.
Publicado: (2018)

The establishment of KORCC (KOrean Renal Cell Carcinoma) database
por: Byun, Seok-Soo, et al.
Publicado: (2016)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Capecitabine in the treatment of metastatic renal cell carcinoma
por: Oevermann, K, et al.
Publicado: (2000)

Targeted therapy for metastatic renal cell carcinoma
por: Patel, P H, et al.
Publicado: (2006)

Sorafenib in the management of metastatic renal cell carcinoma
por: Guevremont, C., et al.
Publicado: (2009)

Metastatic Renal Cell Carcinoma Change Vascularity
por: Azuma, Takeshi, et al.
Publicado: (2012)

Axitinib for the Management of Metastatic Renal Cell Carcinoma
por: Escudier, Bernard, et al.
Publicado: (2012)

Systemic therapy in metastatic renal cell carcinoma
por: Bedke, Jens, et al.
Publicado: (2016)

Metastatic renal cell carcinoma presenting with melena
por: Sadhale, Ashwini, et al.
Publicado: (2018)

Therapeutic Sequencing in Metastatic Renal Cell Carcinoma
por: Maia, Manuel Caitano, et al.
Publicado: (2017)

Sequential Therapy in Metastatic Renal Cell Carcinoma
por: Hirsch, Bradford R., et al.
Publicado: (2016)

Contemporary Treatment of Metastatic Renal Cell Carcinoma
por: Stukalin, Igor, et al.
Publicado: (2016)

Percutaneous resection of metastatic renal cell carcinoma
por: Toussi, Amir, et al.
Publicado: (2019)

Cutaneous metastatic renal cell carcinoma to the scalp
por: Yang, Hyee Jae, et al.
Publicado: (2019)

Metastatic renal cell carcinoma in the thyroid gland
por: Cruz, Mark M., et al.
Publicado: (2020)

Update on the treatment of metastatic renal cell carcinoma
por: Medina López, Rafael Antonio, et al.
Publicado: (2022)

Treatment of Refractory Metastatic Renal Cell Carcinoma
por: Vento, Joseph A., et al.
Publicado: (2022)

The Gut Microbiome and Metastatic Renal Cell Carcinoma
por: Meza, Luis, et al.
Publicado: (2023)

EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma
por: Liu, Lijun, et al.
Publicado: (2018)

Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort
por: Seon, Dong Young, et al.
Publicado: (2020)

Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model
por: Shin, Dongrul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1q4bjrrq3d3mcse5c502qennqn